13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Nephrotoxicity <strong>of</strong>Chemotherapeutic DrugsNephrotoxicity is an inherent adverse effect <strong>of</strong> certainanticancer drugs. Mechanisms <strong>of</strong> nephrotoxicity includechemotherapy induced damage to vasculature or structures <strong>of</strong>the kidneys, haemolytic uraemic syndrome and prerenalperfusion deficits. Patients with cancer are frequently at risk<strong>of</strong> renal impairment secondary to disease-related and iatrogeniccauses.Evaluation <strong>of</strong> Renal Function: In humans, the assessment<strong>of</strong> renal function is mainly done by the measurement <strong>of</strong>glomerular filtration rate (GFR) (1). Normal values, whichare related to age, sex, and body size, are approximately 130mL/min/1.73 m 2 in young men and 120 mL/min/1.73 m 2 inyoung women. Mean values decline as people age (2). Serumcreatinine is dependent on age, gender, race, body size, diet,certain drugs, and laboratory analytic methods (3). In earlyrenal disease, GFR can decrease substantially, without changesin serum creatinine. In late renal disease, the serum creatininelevel may rise disproportionately as GFR falls. The serumcreatinine does not significantly change until the Creatinineclearance rate (CCR) is less than 70 mL/min/1.73 m 2 there<strong>for</strong>ethe use <strong>of</strong> a single reference range <strong>for</strong> serum creatinine to447

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!